is the selling vol thinning??, page-10

Jen - bad form bring up the past. Get your webcam fired up girl!

On PRR. The milestones letter is in the mail and may be striking some interest. Otherwise it is just more of the 'collecting' going on. I know of at least 6 people who are accumulating this stock (no - none are hotcopperites) and are in no hurry. The gate closes sometime between now and the end of June.

A few little tidbits for those who really are in this stock and not just joining the thread - eG Capital don't want to release their research just yet - not entirely sure why - probably a bit of market timing but also hearing there are some negotiations going on they want to include - particularly relevant to increasing the appeal to insto's apparently.
There is at least 1 more Arthron deal to be signed in the next 8 weeks. Te biggext part of the Arthron technology (antibodies) still hasn't been negotiated on and may be left as the jewel in the crown for a trade sale. The recent announcement of 3 new patents from the ARI has cemented the IP for the AstraZ negiotiations - expecting something in June on that. Also 'talks' with BioMira about interim data stuff which will accelerate the development of CancerVac despite the Phase IIa trial not due to complete till later next year.

Treat all with caution but if any of them emerge it will be the catalyst PRR needs and some are going to happen in the next 8 weeks. Any tax loss selling will be usually be done by mid June so the window is closing.

Jerry on SS has latched onto something with Health Canada which if true will be huge - he is talking about Health Canada APPROVING BioMira/Merck's BLP25 MUC1 trial with a further safety trial. I don't know how this can be done but if it is true then it wil re-rate Cancer Vaccine technology companies overnight and PRR is BioMira/Merck's little brother on the MUC1 line but with a more successful approach.